Independent Educational Grants (Alkermes)

Independent Educational Grants (Alkermes) is sponsored by Alkermes. Alkermes supports continuing medical education with grants for educational activities focused on improving patient care and public health in therapeutic areas such as Schizophrenia, Bipolar Disorder, Narcolepsy, and Idiopathic Hypersomnia.

Medical Education Grants | Alkermes Alkermes supports continuing medical education with grants for educational activities focused on pragmatic approaches to improving patient care and public health. We hope to contribute to an improved understanding of the underlying mechanisms of the diseases we research and their relevance to medications, as well as psychosocial interventions.

Grant funding may be available for activities, including live, print, enduring or web-based continuing medical education (CME) activities. Accredited CME activities are preferred. Alkermes is currently accepting grant proposals related to: Schizophrenia and Bipolar Disorder Learners of interest: Narcolepsy and Idiopathic Hypersomnia Learners of interest: Sleep Medicine Specialists For all questions, please contact: Med.

Ed@alkermes. com Only organizations based in the U.S. may apply. Medical education grants may be awarded to (i) nonprofit organizations with tax exempt status under the U.S. Internal Revenue Code or (ii) for-profit organizations that are accredited continuing medical education providers.

Requests must be submitted online by the educational provider. Submissions are due at least 90 days in advance of the activity date. Alkermes is currently accepting proposals that address the topic areas listed below for Schizophrenia, Bipolar Disorder, Narcolepsy, and Idiopathic Hypersomnia.

Understanding patient-centered approaches to address one or more of the following challenges in the care of patients with schizophrenia: Practical training in long-acting injectable (LAI) administration Optimizing patient treatment across stages of illness, including side effects and polypharmacy considerations Long term medication adherence strategies for long acting injectables Consideration of co-occurring disorders in treatment planning Understanding patient-centered approaches to address one or more of the following challenges in the care of patients with bipolar disorder: Optimizing patient treatment across stages of illness, including side effects and polypharmacy considerations Treatment of mixed states Long term medication adherence strategies for oral medications Consideration of co-occurring disorders in treatment planning Narcolepsy and Idiopathic Hypersomnia Understanding the pathophysiology of, and the role of orexin neuropeptides in, Excessive Daytime Sleepiness (EDS), Narcolepsy and/or Idiopathic Hypersomnia Clinical Strategies to improve earlier screening and diagnosis of patients with Narcolepsy and/or Idiopathic Hypersomnia Elucidate the complexity of narcolepsy and/or Idiopathic Hypersomnia patients and their predisposed neurological, psychiatric, metabolic, endocrine, hepatic and GI co-morbidities For questions, please contact: Med.

Ed@alkermes. com . You are now leaving Alkermes.

com. Alkermes assumes no responsibility for information or statements on external websites.